miR-340 Reverses Cisplatin Resistance of Hepatocellular Carcinoma Cell Lines by Targeting Nrf2-dependent Antioxidant PathwayLiang Shi, Fang Zheng, Lili Wu et al.|Asian Pacific Journal of Cancer Prevention|2015Cited by 89
JNK‐IN‐8, a c‐Jun N‐terminal kinase inhibitor, improves functional recovery through suppressing neuroinflammation in ischemic strokeJianjian Zheng, Wujun Geng|Journal of Cellular Physiology|2019Cited by 77